Previous close | 0.2500 |
Open | 0.7500 |
Bid | 0.0000 |
Ask | 1.3500 |
Strike | 5.00 |
Expiry date | 2024-11-15 |
Day's range | 0.7500 - 0.7500 |
Contract range | N/A |
Volume | |
Open interest | 1 |
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
LOS ANGELES, June 17, 2024 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or “IMMX”), a clinical-stage biopharmaceutical company trailblazing cell therapies in autoimmune disease, today announced that it will present and host institutional investor meetings at the Stifel 2024 Cell Therapy Forum. Stifel 2024 Cell Therapy Forum - Immix Biopharma Date:Tuesday, July 9, 2024Presentation: Immix Biopharma to presentLocation:VirtualInvestor Meetings:The IMMX Team will be
Generally, when a single insider buys stock, it is usually not a big deal. However, when several insiders are buying...